Sanofi

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Sanofi and buy or sell other stocks, ETFs, and their options commission-free!

About SNY

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. 

CEO
Paul Hudson
CEOPaul Hudson
Employees
84,587
Employees84,587
Headquarters
Paris, Ile-de-France
HeadquartersParis, Ile-de-France
Founded
1994
Founded1994
Employees
84,587
Employees84,587

SNY Key Statistics

Market cap
128.08B
Market cap128.08B
Price-Earnings ratio
22.28
Price-Earnings ratio22.28
Dividend yield
2.76%
Dividend yield2.76%
Average volume
3.83M
Average volume3.83M
High today
$52.92
High today$52.92
Low today
$52.23
Low today$52.23
Open price
$52.86
Open price$52.86
Volume
5.49M
Volume5.49M
52 Week high
$60.12
52 Week high$60.12
52 Week low
$45.80
52 Week low$45.80

SNY News

TipRanks 20h
Sanofi Reports Strong Q1 2025 Performance

Sanofi SA ( (SNY) ) has released its Q1 earnings. Here is a breakdown of the information Sanofi SA presented to its investors. Sanofi SA, a leading global heal...

TipRanks 1d
Sanofi Reports Strong Q1 2025 Performance and Confirms Guidance

Sanofi ( (SNY) ) has provided an announcement. In April 2025, Sanofi reported a strong performance for the first quarter, with a 9.7% increase in sales at cons...

Benzinga 1d
French Drugmaker Sanofi Clocks 20% Q1 Profit Growth, Forecasts Strong Rebound In Annual Profit

Sanofi SA SNY reported Thursday a first-quarter 2025 business operating income of 2.9 billion euros ($3.06 billion), up 20.1% year over year and 18.7% in consta...

French Drugmaker Sanofi Clocks 20% Q1 Profit Growth, Forecasts Strong Rebound In Annual Profit

Analyst ratings

84%

of 25 ratings
Buy
84%
Hold
16%
Sell
0%

More SNY News

Seeking Alpha 1d
EU pharma majors Sanofi, Roche trade flat after reiterated guidance

Shares of Sanofi (NASDAQ:SNY) and Roche (OTCQX:RHHBY) were flat in European trading on Thursday after the EU pharma giants reaffirmed their full-year forecasts...

EU pharma majors Sanofi, Roche trade flat after reiterated guidance
TipRanks 1d
Sanofi’s Strong Financial Performance and Promising Pipeline Justify Buy Rating

Sanofi (SNYNF – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Graham Parry from Bank of America Securit...

TipRanks 2d
Innate Pharma announces EUR 15M capital increase from Sanofi

Innate Pharma (IPHA) announced a EUR 15M capital increase subscribed by Sanofi (SNY). As announced on April 23 and given the satisfactory market conditions, San...

TipRanks 2d
Innate Pharma Regains Rights on CD123 ANKET® and Announces Sanofi’s Strategic Investment

Innate Pharma SA ( (FR:IPH) ) just unveiled an announcement. Innate Pharma announced on April 23, 2025, that it will regain its rights to the CD123 targeting A...

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.